Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2017-06-02 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2017-06-02 English
AMENDMENT NO. 4 TO SCHEDULE 13D
Major Shareholding Notification
2017-06-02 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the year ended December 31, 2016. It references the Conflict Minerals Report as an exhibit and discusses compliance with SEC rules under the Dodd-Frank Act. The document length is 3359 characters, which is relatively short and primarily serves as a disclosure filing rather than a full report. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2017-05-31 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2017-05-30 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities under the Securities Exchange Act. It specifically registers 1.300% Senior Notes due 2025 for listing on the New York Stock Exchange. The document includes references to prospectus supplements and indentures but does not contain financial statements or detailed financial performance data. It is a regulatory filing related to securities registration rather than a financial report or announcement of results. The document length is 3708 characters, which is relatively short and consistent with a regulatory filing form. Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-05-30 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 30, 2017, reporting the completion of a public offering of senior notes by Baxter International Inc. It includes details about the underwriting agreement, indenture, and related exhibits. The content focuses on a financing event, specifically the issuance of debt securities. There are no financial statements or earnings data presented, nor is it an announcement of voting results, management changes, or legal proceedings. The primary subject is the company's capital raising activity through debt issuance. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the financing transaction, not just an announcement or a certification, supporting a high confidence in classification.
2017-05-30 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.